Skip to content

Does stage of menstrual cycle affect recovery after surgery in premenopausal women?

Impact of hormonal cycle on postoperative quality of recovery in premenopausal women.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12618000240246
Acronym
QoRHm
Enrollment
191
Registered
2018-02-14
Start date
2019-05-31
Completion date
2021-10-29
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

‘A good recovery’ after anaesthesia and surgery is a key objective for patients and their treating team. It is not simply avoidance of complications, but also freedom from discomfort, postoperative nausea, and a rapid return to preoperative levels of function and psychological wellbeing. Delayed or incomplete recovery can have wide-ranging effects on an individual and those around them. The concept of a ‘good recovery’ is patient-centred, thus it is the patient’s assessment of their recovery that is of interest. Our aim is to determine whether stage of menstrual cycle affects quality of recovery after surgery in premenopausal women. Cycle stage will be measured by questionnaires and preoperative hormone blood levels. Quality of recovery will be assessed on the day after surgery by a patient-reported questionnaire which assesses pain, physical comfort, physical independence, emotions and psychological support. This study may provide information on why women generally have a worse recovery after anaesthesia and surgery when compared with men. If a link between menstrual cycle and postoperative recovery is found, women could choose the best time for elective surgery, to improve recovery, reduce pain, nausea and vomiting, as well as limit the side-effects of treatment of these conditions. The study's findings may encourage research into quality of recovery in peri- and postmenopausal women receiving hormone replacement therapy, a group who typically undergo more extensive surgery with a prolonged recovery. This study will be undertaken at Epworth HealthCare, a large tertiary healthcare organisation in Victoria, Australia. The researchers are anaesthesia and women’s health clinicians with an interest in patient-centred clinical outcomes research.

Interventions

Our aim is to determine whether stage of hormonal cycle affects quality of recovery after surgery in premenopausal women. Cycle stage will be measured by questionnaire and preoperative sex hormone blood levels. Quality of recovery will be measured by the Quality of Recovery-15 (QoR-15) score on postoperative day 1. Participants will be followed up for 3 days postoperatively (secondary outcome measurement). Our hypothesis is that stage of hormonal cycle affects quality of postoperative recovery i

Our aim is to determine whether stage of hormonal cycle affects quality of recovery after surgery in premenopausal women. Cycle stage will be measured by questionnaire and preoperative sex hormone blood levels. Quality of recovery will be measured by the Quality of Recovery-15 (QoR-15) score on postoperative day 1. Participants will be followed up for 3 days postoperatively (secondary outcome measurement). Our hypothesis is that stage of hormonal cycle affects quality of postoperative recovery in premenopausal women. Premenopausal women aged 18-45 years undergoing elective surgery will be classified by follicular or luteal phase of menstrual cycle. This will be done by preoperative patient questionnaire and blood progesterone and luteinising hormone levels.

Sponsors

Epworth Richmond
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

1. premenopausal women aged 18 to 45 years 2. having a general anaesthetic for elective wisdom teeth extraction or laparoscopic cholecystectomy

Exclusion criteria

Participants will be excluded if they are 1. using hormonal contraception (oral contraceptive pill, hormone-impregnated intrauterine device, subcutaneous implants) or treated with sex hormone therapy for other reasons 2. pregnant or lactating 3. undergone a bilateral oophorectomy 4. known or suspected to be peri- or post-menopausal 5. unable to complete QoR-15 score 6. active cancer 7. systemic disease affecting daily function (ASA 3 or more) 8. contraindication to dexamethasone, current systemic steroid treatment for any reason, insulin-dependent diabetes mellitus 9. regular opioid use 10. previous recruitment in this study.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 11, 2026